RNA-Based Therapeutics With Nutcracker Therapeutics' Dr. Geoff Nosrati
Business Of Biotech · 52 minutes ·

RNA-Based Therapeutics With Nutcracker Therapeutics' Dr. Geoff Nosrati

Nutcracker Therapeutics is a preclinical biopharma company developing  multimodal RNA-based therapeutics for HPV-driven tumors, T-cell lymphoma, and Genitourinary tumors. On this episode of the Business of Biotech, Chief Business Officer Geoff Nosrati, Ph.D. offers a comprehensive view of the RNA-based therapeutics landscape and sheds light on what he perceives as an advantageous position at Nutcracker— the capacity to manufacture RNA in-house.  If you're curious about the expanding science behind  RNA-based therapeutics and their application in biotech,  this conversation with a scientist-turned-chief business officer (Nosrati earned his Ph.D. in Biochemistry and Molecular Biology) is a can't-miss episode. 

Subscribe to the NEW #BusinessofBiotech newsletter at bioprocessonline.com/bob for more real, honest, transparent interactions with the leaders of emerging biotech. It's a once-per-month dose of insight and intel that you'll actually look forward to receiving! Check it out at bioprocessonline.com/bob!

Comments (0)

You Must Be Logged In To Comment

Similar podcasts

Mind Tap with Alternative Therapeutics

Diabetes Dialogue: Technology, Therapeutics, & Real-World Perspectives

Understanding Childhood Cancer With Dr Geoff

Mamaste Yoga® - Prenatal Yoga

Inquiry Based Learning with Dr. Claire Warden

Hard Count with Geoff Baker

Block 'Em Up with Geoff & Duke

A Critical Update on Relapsed/Refractory Diffuse Large B-Cell Lymphoma and CAR T-cell Therapy